Skip to main content

Guidelines for the Treatment of Type 2 Diabetes Mellitus

  • Chapter
  • First Online:
Essentials of SGLT2 Inhibitors in Diabetes

Abstract

Evidence-based clinical practice guidelines are systematically developed statements intended to assist practitioners and patients about making and understanding care decisions for specific clinical circumstances. The evidence base should be obtained using an unbiased and transparent process of systematically reviewing and appraising published clinical research, which is then synthesized into recommendations for clinical practice. There is a hierarchy of evidence involved, from meta-analysis or systematic reviews of randomized controlled trials (RCTs), to case-controlled or cohort studies, to expert opinion. Evidence-based guidelines have largely replaced consensus statements, which typically involves a group of experts meeting and producing a series of recommendations based on the consensus of the group at that time. However, these can be prone to bias depending on the opinions of those involved in the process, and often would be based on a limited literature review which might miss key publications, especially if the results are negative.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. International Diabetes Federation (IDF). Glucose control therapy. In: Global guidelines for type 2 diabetes. Brussels: International Diabetes Federation; 2012. p. 55–64.

    Google Scholar 

  2. Inzucchi SE, Bergenstal RM, Buse JB, Dimant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2012;35:1364–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Inzucchi SE, Bergenstal RM, Buse JB, Dimant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–9.

    Article  PubMed  Google Scholar 

  4. Harper W, Clement M, Goldenberg R, Hanna A, Main A, Retnakaran R, et al. Pharmacologic management of type 2 diabetes. Can J Diabetes. 2013;37 Suppl 1:S61–8.

    Article  PubMed  Google Scholar 

  5. National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management. Last updated December 2015. www.nice.org.uk/guidance/ng28. Accessed 5 Sept 2016.

  6. Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of glycaemic control in people with type 2 diabetes. In: SIGN 116 management of diabetes. Edinburgh: Scottish Intercollegiate Guidelines Network; 2011. p. 39–55.

    Google Scholar 

  7. Qaseem A, Humphrey LL, Sweet DE, et al. Oral pharmacological treatment of type 2 diabetes: a clinical guideline from the American College of Physicians. Ann Intern Med. 2012;15693:218–31.

    Article  Google Scholar 

  8. Garber AJ, Abrahamson MJ, Barzilay JI, et al. AACE/ACE comprehensive diabetes management algorithm 2015. Endocr Pract. 2015;21:438–47.

    Article  PubMed  Google Scholar 

  9. Menéndez Torre E, Lafita Tejedor J, Artola Menéndez S, Milán Núñez-Cortés J, Alonso García A, Puig Domingo M, et al. Nefrologia. 2011;31:17–26.

    PubMed  Google Scholar 

  10. Bundesärztekammer (BÄK) Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes-Langfassung, 1st edition, Version 2. Last updated on September 2013. www.versorgungsleitlinien.de/themen/diabetes2/dm2_Therapie. Accessed 5 Sept 2016.

  11. Japan Diabetes Society. Evidence-based practice guideline for the treatment for diabetes in Japan 2013. www.jds.or.jp/modules/en/index.php?content_id=44. Accessed 5 Sept 2016.

  12. Indian Council of Medical Research. Pharmacological treatment for diabetes. http://icmr.nic.in/guidelines_diabetes/section7.pdf. Accessed 5 Sept 2016.

  13. Lerario AC, Chacra AR, Pimazoni-Netto A, Malerbi D, Gross JL, Oliveira JEP, et al. Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society. Diabetol Metab Syndr. 2010;2:35. http://dmsjournal.biomedcentral.com/articles/10.1186/1758-5996-2-35. Accessed 5 Sept 2016.

  14. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65.

    Article  Google Scholar 

  15. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi S, Gunuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554–9.

    Article  PubMed  Google Scholar 

  16. National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: diagnosis and management of type 2 diabetes in adults. Draft for consultation, January 2015. www.nice.org.uk/guidance/gid-cgwave0612/resources/type-2-diabetes-draft-nice-guideline2. Accessed 5 Sept 2016.

  17. O’Hare JP, Miller-Jones D, Hanif W, et al. The new NICE guidelines for type 2 diabetes – a critical analysis. Br J Diabetes. 2015;15:3–7.

    Article  Google Scholar 

  18. Barnett AH. NICE draft type 2 diabetes guidelines: a cause for concern. Lancet Diabetes Endocrinol. 2015;3:403–5.

    Article  PubMed  Google Scholar 

  19. National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: diagnosis and management of type 2 diabetes in adults. Draft for consultation, June 2015.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Fisher, M. (2017). Guidelines for the Treatment of Type 2 Diabetes Mellitus. In: Essentials of SGLT2 Inhibitors in Diabetes. Adis, Cham. https://doi.org/10.1007/978-3-319-43296-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43296-0_3

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-43294-6

  • Online ISBN: 978-3-319-43296-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics